U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Advanced Sterilization Products - 06/02/2016
  1. Warning Letters


Advanced Sterilization Products

Advanced Sterilization Products

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

 Food and Drug Administration
Los Angeles District
Pacific Region
19701 Fairchild
Irvine, CA 92612-2506

Telephone: 949-608-2900
FAX:          949-608-4415


June 2, 2016

Shlomi Nachman, Company Group, Chairman CSS
Jacqueline Berretta, VP Quality & Compliance CSS
Advanced Sterilization Products, Inc., Division of Ethicon US LLC, Johnson and Johnson Company
33 Technology Drive
Irvine, California 92618-2346

Dear Mr. Nachman and Ms. Berretta:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter (WL #10-10 dated March 12, 2010). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.



CDR Steven E. Porter, Jr.
Los Angeles District Director


Cc: Alex Gorsky, Chairman and Chief Executive Officer
      One Johnson & Johnson Plaza
      New Brunswick NJ 08933

Back to Top